Cluster of differentiation 30, also TNFSF8, a member of the TNR receptor superfamily. Characteristically associated with anaplastic large cell lymphoma, and Hodgkin Lymphoma.
It is the target of brentuximab.
Cluster of differentiation 30, also TNFSF8, a member of the TNR receptor superfamily. Characteristically associated with anaplastic large cell lymphoma, and Hodgkin Lymphoma.
It is the target of brentuximab.